Purpose: Endothelial damages are one of the most important causes of persistent hypertensive complications. The aim of our study was to discuss the relationship between the molecular markers of endothelial damage, thrombomodulin, and complications in hypertension.
| INTRODUCTION
Hypertension, a common chronic disease, is a leading treatable risk factor for heart, renal disease, and other target organ disease. Kearney et al 1 reported that a quarter of the world ' s adults were suffering from hypertension and predicted the prevalence of hypertension in the world population would rise to 29.2% in 2025, which is one of the main causes of global burden of disease. 2 Since 2000, our country has carried out several hypertension investigations. The research indicated that the prevalence of hypertension in China was increasing. 3 Patients with hypertension have the characteristics of abnormalities of vessel wall, blood components, and blood flow, which are related to the damage of target organs and long-term prognosis. Endothelial injury was considered as an early event in the pathophysiology of hypertension 4 and the basis of many clinical features of hypertension.
Therefore, patients with hypertension should be judged by markers of endothelial damage that are readily available in routine clinical practice. Thrombomodulin, a transmembrane glycoprotein, expressed abundantly on the endothelial surface of blood vessels, 5 first proposed and confirmed by Esmon in 1981, is a high-affinity receptor for thrombin on the surface of endothelial cells. It mediates anticoagulant effect through activation of protein C 6 and has been implicated in the endothelial regulation of fibrinolysis and coagulation. 7 It also has the function of maintaining vascular homeostasis and protecting endothelial cells. 8 Under normal physiological conditions, the concentration of thrombomodulin in the blood is little; 9 while the endothelial cells are damaged, thrombomodulin is secreted abnormally and released into the blood, 10 which appears secondary to damage vascular endothelial cells. At present, thrombomodulin has been demonstrated to be a specific biomarker of endothelial cell injury in medicine 11, 12 for the diagnosis and antidiastole of clinical diseases. Thrombomodulin as abnormalities of levels may relate to complications of hypertension and determination of blood pressure itself. The determination of blood levels may contribute to the early diagnosis of subclinical target organ damage. Our aim was to explore the significance of its plasma levels in the pathogenesis of hypertension, by measuring the markers of endothelial injury, thrombomodulin and provide a theoretical basis for its clinical application. Hypertension grading meted the given criteria, Chinese guidelines for the management of hypertension 13 (as Table 1 ). Patients with diabetes mellitus, severe pulmonary disease, acute or chronic liver disease, impaired renal function, and peripheral vascular disease were excluded from the study.
| MATERIALS AND METHODS

| Study population
| Blood pressure measurements
Brachial systolic blood pressure and diastolic blood pressure were measured in the right arm with a patient in seated position, assessed by a trained health professional. Thrice evaluations were performed for each patient.
| Laboratory measurements
Venous blood samples were collected in tubes containing sodium citrate, with anticoagulant ratio of 1:9. The blood samples were centrifuged at 1371 g. The level of thrombomodulin was measured by high sensitivity chemiluminescence apparatus, Sysmex Because the light production increases in proportion to thrombomodulin concentration, sample thrombomodulin concentrations can be obtained with a calibration curve prepared with calibrators.
Compared with traditional method of ELISA, chemiluminescence rapidly determined automatically the concentration of thrombomodulin in the sample, by counting the photon emission in the enzyme reaction, which has higher sensitivity, shorter detection time, and wider diagnostic range.
| Statistical analysis
Statistical analysis was performed using SPSS 20.0 software.
Differences between the study groups were determined using t test or Mann-Whitney U test for independent samples or Kruskal-Wallis H test for multigroup. According to the distribution of the data, the chi-square test was used to calculate the statistical significance for the differences in qualitative parameters. A P value of < .5 was taken to be statistically significant.
| RESULTS
The general characteristics of study groups are listed in Table 2 .
A total of 132 cases of hypertensive patients were selected as research subjects, including 13 (9.85%) patients with complications.
Among them, the complications of patients with heart diseases consisted of 10 (76.92%) patients, with renal dysfunctions 5 (38.46%) patients, with cerebrovascular diseases 1 (7.69%) patient. Of which 3 cases were complicated with more than two complications. As expected, hypertensions with complications group had significantly higher systolic blood pressure (SBP) and diastolic blood pressure (DBP) measurements than without complications did (P = .029;
.006). However, the characteristics of the subjects, including age, sex, smoking, and drinking history, were the same in the two groups (P > .05).
Comparison of thrombomodulin levels in hypertensive patients with or without complications As shown in Figure 1 , the concentrations ference was significant (P = .001).
The cutoff value with relevant sensitivity and specificity was predicted by ROC analysis. As shown in Figure 2 , the area under the curve corresponding to the thrombomodulin proved to the ideal indicator for anticipating hypertensive complications. The optimum cutoff concentration of thrombomodulin for diagnosing the hypertensive complications was determined to be 15.5 TU/mL. At this level, the sensitivity and specificity were 92.3% and 63%, respectively, with a positive predictive value of 21.4% and negative predictive value of 98.7%.
Comparison of thrombomodulin levels in patients with different grades of hypertension As shown in Figure 3 , with the increase in hypertension grading, the concentration of thrombomodulin was 
| DISCUSSION
With the improvement of people's living standards, China has entered an aging society. The incidence of a variety of chronic diseases increased year by year. Among them, the incidence of hyperten- Data are expressed as mean ± SD. F, female; M, male; SBP, systolic blood pressure; DBP, diastolic blood pressure.
T A B L E 2 Characteristics of hypertensive people with and without complications F I G U R E 1 Without: hypertension without complications; with: hypertension with heart diseases, renal dysfunctions or cerebrovascular diseases. Differences in the hypertensive patients between the two groups were analyzed using Mann-Whitney U test F I G U R E 3 Blood pressure levels of all patients were graded according to guidelines, Chinese guidelines for the management of hypertension. The difference was significant (P = .007) of cardiovascular events in hypertensive patients was significantly increased. 16, 17 Therefore, the treatment and prevention of early hypertension needed to be enhanced. Hypertension is characterized by endothelial damage. The derangement of endothelial function in hypertension may be partly caused by genetic factors, or due to elevated blood pressure itself, due to the relative effects of blood pressure and smooth muscle cells. Vascular sclerosis and peripheral vascular resistance caused by endothelial injury, is a crucial cause of hypertension occurrence and development. 18 As a mechanical barrier for circulating blood and vascular smooth muscle, endothelial impairment is a key mechanism in the pathogenesis of hypertension and its related clinical complications. 19 Previous studies of cultured human umbilical vein endothelial cells showed that the release of thrombomodulin was not secreted by endothelial cells but derived from injured cells. 20 There is a positive correlation of thrombomodulin concentration in blood circulation with the degree of injury of endothelial cells. 6 Thrombomodulin as abnormalities of levels is specific plasma markers of endothelial damage.
11,12
We found increased levels of plasma thrombomodulin in patients In the course of disease development, we highly recommend to use the 15.5 TU/mL, thrombomodulin levels, for screening hypertensive target organ damage. As this test is more effective than the clinical examination alone, it can be used as a screening test for hypertensive complications.
| CONCLUSIONS
In conclusion, elevated levels of thrombomodulin in hypertensive patients reflect early endothelial damage. Measurements of circulating endothelial cell damage marker, thrombomodulin, can be important for improving diagnosis, monitoring, and more effective strategies for the treatment of organ dysfunction in hypertensive patients. Endothelial injury in hypertension is crucial both for the development of the disease process and an important therapeutic target. Detecting the levels of thrombomodulin also becomes crucial.
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